India-based synthetic biology startup StrainX Bioworks has raised $13 million (approximately ₹124 crore) in a new funding round led by Prime Venture Partners and Leo Capital.
- Multiple Investors Participate in Funding Round
- Company Targets Global Synthetic Biology Opportunity
- Startup Focuses on Precision Fermentation Technology
- Fermentation Technology Gains Momentum Beyond Pharma
- StrainX Tests Production at Industrial Scale
- Investors See Growth Potential in Biotech Innovation
- India’s Synthetic Biology Sector Expanding
- Conclusion
The investment highlights growing investor interest in synthetic biology, precision fermentation, and alternative ingredient technologies as demand rises for sustainable and scalable biotechnology solutions globally.
Multiple Investors Participate in Funding Round
Apart from Prime Venture Partners and Leo Capital, the funding round also saw participation from:
- Good Startup
- Sparrow Capital
- Sun Icon Ventures
- Dholakia Ventures
- WindT Angels
WindT Angels was founded by alumni from Indian Institute of Technology Delhi.
The company plans to use the fresh capital to:
- Strengthen research and development
- Expand fermentation production capacity
- Hire engineers and scientists
- Accelerate global product launches
- Build partnerships with food and ingredient companies worldwide
Company Targets Global Synthetic Biology Opportunity
Akshay Mittal, Founder and CEO of StrainX Bioworks, said the funding reflects investor confidence in the company’s positioning within the synthetic biology sector.
According to Mittal, only a limited number of companies globally are working in the advanced fermentation and synthetic biology segment at scale.
He also highlighted India’s advantages in:
- Fermentation-led manufacturing
- Biotechnology talent
- Engineering expertise
- Cost-efficient production capabilities
Industry analysts believe India could emerge as a major global hub for precision fermentation and bio-manufacturing as the sector expands internationally.
Startup Focuses on Precision Fermentation Technology
Founded in 2023 by IIT Delhi alumni Akshay Mittal and Alok Malaviya, Bhopal-based StrainX Bioworks operates in the fields of:
- Synthetic biology
- Precision fermentation
- Microbial engineering
- Bio-manufacturing
The startup develops engineered microbes capable of producing:
- Functional ingredients
- Proteins
- Bio-based molecules
- Alternative compounds
through controlled industrial fermentation systems.
The company said it spent nearly two years building its:
- Microbe engineering platform
- Fermentation systems
- Scale-up infrastructure
- Product development capabilities
before publicly launching its operations.
Fermentation Technology Gains Momentum Beyond Pharma
Precision fermentation has been widely used in the pharmaceutical industry for decades. However, the technology is now rapidly expanding into:
- Food technology
- Alternative proteins
- Consumer products
- Nutrition
- Sustainable ingredients
The process involves growing engineered microbes inside industrial fermentation tanks to produce target ingredients at scale.
Industry experts say declining production costs and increasing sustainability focus are accelerating adoption across global industries.
StrainX Tests Production at Industrial Scale
According to the company, StrainX has already completed testing at:
- 10,000-litre fermentation scale
The startup is now working toward:
- Larger-scale manufacturing expansion
- Commercial product launches in India
- International market entry, including the United States
The company said its integrated platform combines:
- Biotechnology
- Fermentation systems
- Process engineering
- Product development
- Manufacturing scale-up
to reduce the time required to move from laboratory research to industrial production.
Investors See Growth Potential in Biotech Innovation
Brij Bhushan, Managing Partner at Prime Venture Partners, said StrainX stood out because of its combination of:
- Scientific innovation
- Strong execution capabilities
Investors are increasingly focusing on synthetic biology startups due to growing opportunities in:
- Sustainable manufacturing
- Alternative food ingredients
- Climate-friendly production systems
- Bio-based industrial solutions
India’s Synthetic Biology Sector Expanding
India’s biotechnology and synthetic biology ecosystem has been growing steadily with increased activity in:
- Bio-manufacturing
- Alternative proteins
- Fermentation technologies
- Deep-tech research
- Climate-focused biotechnology
Industry estimates suggest India’s broader biotech industry could become a major global growth market over the next decade.
Experts believe synthetic biology and precision fermentation could play a key role in:
- Sustainable food systems
- Industrial decarbonisation
- Supply chain resilience
- Resource-efficient manufacturing
Conclusion
StrainX Bioworks’ latest funding round reflects the increasing global interest in synthetic biology and precision fermentation technologies.
As industries search for scalable and sustainable alternatives to traditional manufacturing processes, biotechnology startups developing advanced fermentation platforms are expected to attract growing investment and commercial opportunities.
With expansion plans across production, research, and international markets, StrainX aims to strengthen its position in the rapidly evolving global bio-manufacturing ecosystem.
